CytomX Therapeutics, Inc.
$3.21
-0.21 (-6.14%)
Price as of Aug 28, 2026 market close
Performance
- 1 Month
- -2.1%
- 3 Months
- -10.8%
- YTD
- -24.6%
- 1 Year
- +55.1%
Price return, based on split- and dividend-adjusted closing prices.
Risk
- Volatility 1-year annualized
- 89.4%
- Largest decline max drawdown, since Aug 2025
- -56.9%
- Risk-adjusted return Sharpe ratio, 1-year
- 0.91
Own CTMX?
See how CTMX contributes to your portfolio's return, allocation, and risk.
7-day free trial, then $9/month.